All In Biotech

Drug Trial Radar · NCT05704725

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

An Open Label, Two-Arm Study in Subjects With Chorioretinal Vascular Disease to Evaluate ABP 938 and Aflibercept (Eylea®) in a Prefilled Syringe

Last checked: Nov 19, 2026Latest source record: Feb 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

49

Actual

Start

Jan 23, 2023

Primary completion

Feb 17, 2023

Study completion Mar 24, 2023

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Jan 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to is to assess the ability of retina specialists to successfully administer, via an intravitreal (IVT) injection, a 2 mg dose of ABP 938, using the ABP 938 aflibercept prefilled syringe (PFS), compared to a 2 mg dose of aflibercept using the aflibercept PFS.

Conditions

  • Chorioretinal Vascular Disease

Interventions

  • ABP 938Drug

    IVT injection

  • AfliberceptDrug

    IVT injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of IVT Injections Successfully AdministeredTime frame: Day of IVT injection (study day 1)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Retina Consultants of Texas - Austin Retina

    Austin, Texas

  • Retina Consultants of Texas - Bellaire Retina Center

    Bellaire, Texas

  • Retinal Consultants of Texas - San Antonio Retina Center

    San Antonio, Texas

  • Retina Consultants of Texas - The Woodlands Retina Center

    The Woodlands, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.